One particular study indicated that histopathologic grade II or III IDH-wild-type diffuse astrocytic gliomas, characterized by chromosomal anomalies such as +7/−10, EGFR amplification or TERT promoter mutations, are prognostically equivalent to histologically confirmed glioblastoma [24]. This evidence concerns the gene IDH2 and glioblastoma.